PL3569697T3 - Terapia komórkami macierzystymi w patologiach endometrium - Google Patents

Terapia komórkami macierzystymi w patologiach endometrium

Info

Publication number
PL3569697T3
PL3569697T3 PL19169309T PL19169309T PL3569697T3 PL 3569697 T3 PL3569697 T3 PL 3569697T3 PL 19169309 T PL19169309 T PL 19169309T PL 19169309 T PL19169309 T PL 19169309T PL 3569697 T3 PL3569697 T3 PL 3569697T3
Authority
PL
Poland
Prior art keywords
stem cell
cell therapy
endometrial
pathologies
endometrial pathologies
Prior art date
Application number
PL19169309T
Other languages
English (en)
Inventor
Carlos Simon
Javier SANTAMARIA
Antonio PELLICER
Irene CERVELLO
Original Assignee
Asherman Therapy, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asherman Therapy, S.L. filed Critical Asherman Therapy, S.L.
Publication of PL3569697T3 publication Critical patent/PL3569697T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
PL19169309T 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium PL3569697T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462013121P 2014-06-17 2014-06-17
EP19169309.2A EP3569697B8 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies
PCT/IB2015/001715 WO2015193737A1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies
EP15781411.2A EP3158057B1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies

Publications (1)

Publication Number Publication Date
PL3569697T3 true PL3569697T3 (pl) 2022-07-04

Family

ID=54329860

Family Applications (3)

Application Number Title Priority Date Filing Date
PL19169309T PL3569697T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium
PL22150013.5T PL4012023T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium
PL15781411T PL3158057T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL22150013.5T PL4012023T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium
PL15781411T PL3158057T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium

Country Status (22)

Country Link
US (1) US11129851B2 (pl)
EP (3) EP3158057B1 (pl)
JP (2) JP6920062B2 (pl)
CN (2) CN107073040A (pl)
AU (1) AU2015275798B2 (pl)
BR (1) BR112016029558A2 (pl)
CA (1) CA2952559C (pl)
CY (2) CY1122615T1 (pl)
DK (2) DK3569697T3 (pl)
ES (3) ES2736117T3 (pl)
HR (3) HRP20191240T1 (pl)
HU (3) HUE058328T2 (pl)
LT (2) LT3569697T (pl)
MX (1) MX377300B (pl)
PL (3) PL3569697T3 (pl)
PT (2) PT3569697T (pl)
RS (3) RS59210B1 (pl)
RU (1) RU2725006C2 (pl)
SI (2) SI3569697T1 (pl)
SM (3) SMT202400270T1 (pl)
TR (1) TR201910410T4 (pl)
WO (1) WO2015193737A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
CA2875918A1 (en) 2012-06-06 2013-12-12 Fundacio Institut De Recerca Biomedica (Irb Barcelona) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
HK1213946A1 (zh) 2012-10-12 2016-07-15 Inbiomotion S.L. 用於使用c-maf对前列腺癌转移进行诊断、预後和治疗的方法
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
EP2975138A2 (en) 2013-03-15 2016-01-20 Fundació Institut de Recerca Biomèdica (IRB Barcelona) Method for the diagnosis, prognosis and treatment of cancer metastasis
HRP20191240T1 (hr) 2014-06-17 2019-11-01 Igenomix S L Terapija matičnim stanicama kod patologija endometrija
KR20230067696A (ko) * 2016-06-23 2023-05-16 티톤 바이오테크, 인크. 부갑상선 호르몬 1 수용체를 발현하는 세포 및 그의 용도
RU2699029C1 (ru) * 2018-12-10 2019-09-03 Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке
RU2741621C1 (ru) * 2020-09-25 2021-01-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения внутриматочных синехий
CN117979980A (zh) 2021-07-23 2024-05-03 车医科学大学校产学协力团 用于预防或治疗阿谢曼综合征的包含分离的线粒体作为活性成分的药物组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0473612B1 (en) 1989-05-05 1996-07-31 Northern Sydney Area Health Service Fertility enhancement
US6979533B2 (en) 1992-06-12 2005-12-27 The Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
CA2203718A1 (en) 1997-04-25 1998-10-25 University Of British Columbia Cadherin-11 as an indicator of viable pregnancy
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
CA2400065A1 (en) 2000-03-08 2001-09-13 Harvey J. Kliman Methods of diagnosing and monitoring endometrial glandular development
JP2004504275A (ja) 2000-05-24 2004-02-12 シエーリング　アクチエンゲゼルシャフト フィブリン−１の医薬用途
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
AUPR673001A0 (en) 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
DE10139874A1 (de) 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20030186300A1 (en) 2002-03-20 2003-10-02 Ali Akoum Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions
WO2004061074A2 (en) 2002-05-14 2004-07-22 The Board Of Trustees Of The Leland Stanford Junior University Endometrial genes in endometrial disorders
JP2005539016A (ja) 2002-08-02 2005-12-22 シエーリング アクチエンゲゼルシャフト 女性用受胎調節及びホルモン置換療法のための高められた抗ゴナドトロピン活性を有するプロゲステロン受容体モジュレーター
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
WO2004058999A2 (de) 2002-12-21 2004-07-15 Universität Leipzig Verfahren und mittel zur bestimmung von bestimmten zuständen bzw. veränderungen im uterusepithel und im epithel anderer organe
WO2005018796A1 (en) 2003-08-21 2005-03-03 Pamgene B.V. Microarray support for bioprobe synthesis
JP2007504807A (ja) 2003-09-08 2007-03-08 ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
EP1670902A4 (en) 2003-09-08 2008-05-07 Univ Texas METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG
EP1711618B1 (en) 2003-12-23 2010-08-04 Mount Sinai Hospital Corporation Methods for detecting markers associated with endometrial disease or phase
EP1765083A4 (en) 2004-05-28 2008-08-20 Serono Lab USE OF IL-17 TO TREAT FERTILITY DISORDERS
RU2434645C2 (ru) * 2006-03-31 2011-11-27 Конинклейке Филипс Электроникс, Н.В. Системы и методы измерения клеток, использующие ультракороткую т2*-релаксометрию
JP2007278750A (ja) 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
GB0703683D0 (en) * 2007-02-26 2007-04-04 Ark Therapeutics Ltd The treatment of complications in pregnancy
US9259233B2 (en) * 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
WO2009143633A1 (en) 2008-05-30 2009-12-03 Institut De Recherches Cliniques De Montreal Pcsk9 inhibitors and methods of use thereof
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
WO2013057316A2 (en) 2011-10-21 2013-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation
US9423402B2 (en) 2011-11-30 2016-08-23 Singapore Health Services Pte. Ltd. GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
EP2867670B1 (en) 2012-06-27 2018-05-30 Roche Diagnostics GmbH MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
RU2515475C1 (ru) * 2012-11-15 2014-05-10 Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте
CN106662589B (zh) 2014-03-21 2019-07-30 艾基诺米公司 先兆子痫的早期检测
HRP20191240T1 (hr) 2014-06-17 2019-11-01 Igenomix S L Terapija matičnim stanicama kod patologija endometrija

Also Published As

Publication number Publication date
JP6920062B2 (ja) 2021-08-18
CY1125938T1 (el) 2024-02-16
SMT201900400T1 (it) 2019-09-09
SMT202200155T1 (it) 2022-05-12
PL3158057T3 (pl) 2020-05-18
AU2015275798B2 (en) 2021-03-25
ES2910306T3 (es) 2022-05-12
ES2983444T3 (es) 2024-10-23
HUE044823T2 (hu) 2019-11-28
EP4012023A1 (en) 2022-06-15
RS59210B1 (sr) 2019-10-31
DK3569697T3 (da) 2022-04-04
RU2017101147A3 (pl) 2019-02-06
ES2736117T3 (es) 2019-12-26
HUE058328T2 (hu) 2022-07-28
RU2017101147A (ru) 2018-07-17
US20170128492A1 (en) 2017-05-11
LT3569697T (lt) 2022-04-25
EP4012023C0 (en) 2024-05-15
SI3569697T1 (sl) 2022-05-31
HRP20191240T1 (hr) 2019-11-01
WO2015193737A1 (en) 2015-12-23
BR112016029558A2 (pt) 2017-08-22
PT3569697T (pt) 2022-05-02
EP3158057A1 (en) 2017-04-26
EP4012023B1 (en) 2024-05-15
JP2020138984A (ja) 2020-09-03
EP3569697B8 (en) 2022-04-27
RS65719B1 (sr) 2024-08-30
HRP20220419T1 (hr) 2022-05-27
HUE067463T2 (hu) 2024-10-28
EP3569697A1 (en) 2019-11-20
CA2952559C (en) 2023-01-24
PL4012023T3 (pl) 2024-09-02
PT3158057T (pt) 2019-07-19
LT3158057T (lt) 2019-09-25
DK3158057T3 (da) 2019-07-29
RS63093B1 (sr) 2022-04-29
CN107073040A (zh) 2017-08-18
EP3569697B1 (en) 2022-01-05
RU2725006C2 (ru) 2020-06-29
AU2015275798A1 (en) 2017-02-02
SI3158057T1 (sl) 2019-10-30
HRP20240798T1 (hr) 2024-09-27
SMT202400270T1 (it) 2024-07-09
MX2016016756A (es) 2017-11-02
TR201910410T4 (tr) 2019-08-21
JP2017522288A (ja) 2017-08-10
US11129851B2 (en) 2021-09-28
CN116747241A (zh) 2023-09-15
MX377300B (es) 2025-03-07
EP3158057B1 (en) 2019-04-17
CA2952559A1 (en) 2015-12-23
CY1122615T1 (el) 2021-03-12

Similar Documents

Publication Publication Date Title
IL274903A (en) cell
LT3158057T (lt) Endometriumo patologijų terapija su kamieninėmis ląstelėmis
PL3134724T3 (pl) Komórka elektrochemiczna
SG11201607925SA (en) Improved stem cell composition
SG11201610831PA (en) Lithium-sulphur battery
PT3157504T (pt) Composições estimuladoras das células estaminais
SG10202004286UA (en) Integrated single cell sequencing
GB201411985D0 (en) Battery
PL3149792T3 (pl) Ogniwo litowo-siarkowe
SG10201403640XA (en) Stem cells
HK40099394A (zh) 子宫内膜病理状况中的干细胞治疗
GB201406700D0 (en) Cervix cells
GB201416493D0 (en) Polypeptides for use in therapy
GB201416750D0 (en) Cell preparation
ZA201505928B (en) Built in gas-fired braii unit
GB201406606D0 (en) Improvements in transformer design
GB201411798D0 (en) Electrochemical cell
GB201410934D0 (en) T cell